Summary
The interaction of metastatic cells with the host environment occurs, to a large extent, through the cell surface, and the cell cytoskeletal system controls the distribution and motility of cell surface receptors. During metastasis, tumor cells migrate from one organ to another, and the dynamic properties and mechanochemical deformability of disseminated cells play a central role in the process. The studies described hereunder suggest an interrelationship between the cytoskeleton and cell adhesion, which can control and uagment the expression of the metastatic phenotype of neoplastic cells.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 283: 138–146, 1980
Nicolson GL: Cancer metastasis: Organ colonization and the cell surface properties of malignant cells. Biochim. Biophys Acta 495: 113–176, 1982
Fidler IJ: The evolution of biological heterogeneity in metastatic neoplasma. In: Nicolson GL and Milas L (eds) Cancer invasion and metastasis: Biological and therapeutic Aspects. Raven Press, New York, 1984, pp 5–26
Weiss L, Ward PM: Cell detachment and metastasis. Cancer Metastasis Rev 2: 111–124, 1983
Strauli P, Weiss L: Cell locomotion and tumor penetration. Eur J Cancer 13: 1–12, 1977
Scanlon EF, Volkner DD, Oviedo MA, Khandekar JD, Victor TA: Metastatic basal cell carcinoma. J Surg Onc 15: 171–180, 1980
Fidler IJ: The relationship of embolic hemogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer 9: 223–227, 1973
Gasic GJ, Gasic TB, Galanti N, Johnson T, Murphy S: Platelet tumor cell interaction in mice. The role of platelets in the spread of malignant disease. Int J Cancer 11: 704–718, 1973
Liotta LA, Kleinerman J, Saidel GM: The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 36: 889–894, 1976
Raz A, Bucana C, McLellan W, Fidler IJ: Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonization potential. Nature (Lond) 284: 363–364, 1980
Raz A, Lotan R: Lectin-like activities associated with human and murine neoplastic cells. Cancer Res 41: 3642–3647, 1981
Paget S: The distribution of secondary growths of cancer of the breast. Lancet 1: 571–573, 1889
Patel JK, Didolkar MS, Pickren JW, Moore RH: Metastatic pattern of malignant melanoma. Am J Surg 135: 807–810, 1978
Willis RA: The spread of tumors in the human body. London, Butterworths, 1973
Branson KW, Beattie G, Nicolson GL: Selection and altered properties of brain-colonizing metastatic melanoma. Nature (Lond) 272: 543–545, 1978
Fidler IJ, Nicolson GL: Organ sensitivity for implantation survival and growth of B16 melanoma variant tumor lines. J Natl Cancer Inst 57: 1199–1201, 1976
Raz A, Hart IR: Murine melanoma: a model for intracranial metastasis. Br J Cancer 66: 183–189, 1980
Shearman PJ, Longenecker BM: Clonal variation and functional correlation of organ-specific metastasis and an organ-specific metastasis-associated antigen. Int J Cancer 27: 387–395, 1981
Tao T, Matter A, Vogel R, Burger MM: Liver-colonizing melanoma cells selected from B16 melanoma. Int J Cancer 23: 854–957, 1979
Kramer RH, Nicolson GL: Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion. Proc Natl Acad Sci USA 76: 5704–5708, 1979
Nicolson GL, Irimura T, Gonzalez R, Ruoslahti E: The role of fibronectin in adhesion of metastatic melanoma cells to endothelial cells and their basal lamina. Exp Cell Res 135: 461–465, 1981
Warren BA, Vales O: The adhesion of thromboplastic tumor emboli to vessels in vitro. Br J Exp Pathol 53: 301–313, 1972
Raz A, Geiger B: Altered organization of cell-substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities. Cancer Res 42: 5183–5190, 1982
Volk T, Geiger B, Raz A: Motility and adhesive properties of high-and low-metastatic neoplastic cells. Cancer Res 44: 811–824, 1984
Geiger B, Volk T, Raz A: Cell contacts and cytoskeletal organization of metastatic cell variants. Ex Biol Med 10: 39–53, 1985
Zvibel I, Raz A: The establishment and characterization of a new BALB/c angiosarcoma tumor system. Int J Cancer 36: 261–272, 1985
Netland PA, Zetter BR: Metastatic potential of B16 melanoma cells after in vitro selection for organ-specific adherence. J Cell Biol 101: 720–724, 1985
McCarthy JB, Basara ML, Palm SL, Sas F, Furcht LT: The role of cell adhesion proteins—laminin and fibronectin—in the movement of malignant and metastatic cells. Cancer Met Rev 4: 125–152, 1985
Albrecht-Buehler G: The phagokinetic tracks of 3T3 cells. Cell 11: 395–404, 1977
Young RM, Newby M, Meunier J: Relationships between morphology, dissemination, migration, and prostaglandin E2 secretion by cloned variants of Lewis lung carcinoma. Cancer Res 45: 3918–3923, 1985
Badenoch-Jones P, Ramshaw IA: Spontaneous capillary tube migration of metastatic rat mammary adenocarcinoma cells. Invasion and Metastasis 4: 98–110, 1984
Stoker M, O'Neill CH, Berryman S, Waxman V: Anchorage and growth regulation in normal and virus-transformed cells. Int J Cancer 3: 683–693, 1968
Otsuka H, Moskowitz M: Arrest of 3T3 cells in G1 phase in suspension culture. J Cell Physiol 87: 213–220, 1975
Maroudas NG: Growth of fibroblasts on linear and planar anchorage of limiting dimensions. Exp Cell Res 81: 104–110, 1973
Folkman J, Moscona A: Role of cell shape in growth control. Nature 273: 345–349, 1978
Vasiliev JM: Spreading of non-transformed and transformed cells. Biochim Biophys Acta 780: 21–65, 1985
Folkman J, Greenspan HP: Influence of geometry on control of cell growth. Biochim Biophys Acta 417: 211–236, 1975
Brouty-Boye D, Tucker RW, Folkman J: Transformed and neoplastic phenotype reversibility during culture by cell density and cell shape. Int J Cancer 26: 501–507, 1980
Wittelsberger SC, Kleene K, Penman S: Progressive loss of shaperesponsive metabolic controls in cells with increasingly transformed phenotype. Cell 24: 859–866, 1981
Raz A, Ben-Ze'ev A: Growth control and cell spreading differential response in preneoplastic and metastatic cell variants. Int J Cancer 29: 711–715, 1982
Ben-Ze'ev A, Farmer SR, Penman S: Protein synthesis requires cellsurface contact while nuclear events respond to cell shape in anchorgedependent fibroblasts. Cell 21: 365–372 1980
Raz A, Ben-Ze'ev A: Modulation of the metastatic capability in B16 melanoma by cell shape. Science 221: 1307–1310, 1983
Poste G: Tumor cell heterogeneity and the metastatic process. In: Rich MA, Hager J, Furmanski P (eds) Understanding breast cancer. Clinical and laboratory concepts. Marcel Decker Inc New York, 1983, pp 119–143
Schirrmacher V: Shifts in tumor cell phenotypes induced by signals from the microenvironment. Relevance for the immunobiology of cancer metastasis. Immunobiol 157: 89–98, 1980
Stackpole CW, Fornabaio DM, Alterman AL: Phenotypic interconversion of B16 melanoma clonal cell population: Relationship between metastasis and tumor growth rate. Int J Cancer 35: 667–674, 1985
Takenaga K: Enhanced metastatic potential of cloned lowmetastatic Lewis lung carcinoma cells treated in vitro with dimethyl sulfoxide. Cancer Res 44: 1122–1127, 1984
Shiu RP, Paterson JA: Alteration of cell shape adhesion, and lipid accumulation in human breast cancer cells (T-4D7) by human prolactin and growth hormone. Cancer Res 44: 1178–1186, 1984
Nicolson GL, Fidler IJ, Poste G: Effects of tertiary amine local anesthetics on blood-borne implantation and cell surface properties of metastatic mouse melanoma cells. J Natl Cancer Inst 76: 511–519, 1986
Hochman Y, Katz A, Levy E, Eshel S: Substrate-adhering lymphoid cells show impaired tumorigenicity and increased immunogenicity. Nature (Lond) 290: 248–249, 1981
Fogel M, Altevogt P, Schirmacher V: Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J Exp Med 157: 371–376, 1983
Matzku S, Komitowski D, Mildenberger M, Zoller M: Characterization of BSp73, a spontaneous rat tumor and its in vivo selected variants showing different metastasizing capacities. Invasion Metastasis 3: 109–123, 1983
Raz A, Zoller M, Ben-Ze'ev A: Cell configuration and adhesive properties of metastasizing and non metastasizing BSp73 rat adenocarcinoma cells. Exp Cell Res 162: 127–141, 1986
Lotan R, Raz A: Metastatic melanoma cells selected for reduced homotypic aggregation capability exhibited low colony formation in vivo and in culture. Cancer Res 43: 2088–2093, 1983
The Cell in Contact. Edelman GM (ed) UCLA Symposia on Molecular and Cellular Biology. Alan R Liss, New York, 1985 (31)
Obrink B: Epithelial cell adhesion molecules. Exp Cell Res 163: 1–21, 1986
Crossin KL, Carney DH: Evidence that microtubule depolymerization early in the cell cycle is sufficient to initiate DNA synthesis. Cell 23: 61–71, 1981
Maness PF, Walsh RC: Dihydrocytochalasin B disorganizes actin cytoarchitecture and inhibits initiation of DNA synthesis in 3T3 cells. Cell 30: 253–262, 1982
Bockus BJ, Stiles CD: Regulation of cytoskeletal architecture by platelet-derived growth factor, insulin and epidermal growth factor. Exp Cell Res 153: 186–197, 1984
Herman B, Pledger WJ: Platelet-derived growth factorinduced alterations in vinculin and actin distribution in Balb/c-3T3 cells. J Cell Biol 100: 1031–1040, 1985
Ben-Ze'ev A: The cytoskeleton in cancer cells. Biochim biophys Acta 780: 197–212, 1985
Hagmar B, Ryd W: Tumor cell locomotion: a factor in metastasis formation? Influence of cytochalasin B on a tumor dissemination pattern. Int J Cancer 19: 576–580, 1977
Hart IR, Raz A, Fidler IJ: Effect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells. J Natl Cancer Inst 64: 891–900, 1980
Zachary JM, Cleveland G, Kwock L, Lawrence T, Weissmann RM, Nabell L, Fried FA, Staub EV, Risinger MA, Lin S: Actin filament organization of the Dunning R337 rat prostatic adenocarcinoma system: Correlation with metastatic potential. Cancer Res 46: 926–932, 1986
Friedman E, Verderame M, Winawer S, Pollack R: Actin cytoskeletal organization loss in the benign-to-malignant tumor transition in cultured human colonic epithelial cells. Cancer Res 44: 3040–3050, 1984
Geiger B: A 130-K protein from chicken gizzard: its localization at the termini of microfilament bundles in cultured chicken cells. Cell 18: 193–205, 1979
Geiger B: Membrane-cytoskeleton interaction. Biochim Biophys Acta 737: 305–341, 1983
Bubenik J, Perlmann P, Fenyo EM, Jandlova T, Schajova E, Malkovsky M: Inverse correlation between cell-surface adhesiveness and malignancy in mouse fibroblastoid cell lines. Int J Cancer 23: 392–396, 1979
Reich S, Rosin H, Levy M, Karkash R, Raz A: Cellsubstrate interaction: a method for evaluating the possible correlation between metastatic phenotype and cell surface energy. Exp Cell Res 153: 556–460, 1984
Intermediate Filaments. Wang E, Fischman D, Liem RKH, Sun T-T (eds) Ann N Y Acad Sci 455: 1–829, 1985
Osborn M, Weber K: Intermediate filaments: cell-type-specific markers in differentiation and pathology. Cell 31: 303–306, 1982
Osborn M, Weber K: Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab Invest 48: 372–397, 1983
Ben-Ze'ev A: Cell configuration related control of vimentin biosynthesis and phosphorylation in cultured mammalian cells. J Cell Biol 97: 858–865, 1983
Bernal SD, Baylin SB, Shaper JH, Gardar AF, Chen LB: Cytoskeletal-associated proteins of human lung cancer cells. Cancer Res 43: 1798–1808, 1983
Ben-Ze'ev A, Raz A: The relationship between the organisation and synthesis of vimentin and the metastatic capability of B16 melanoma cells. Cancer Res 45: 2632–2641, 1985
Ben-Ze'ev A, Zoller M, Raz A: Differential expression of intermediate filament proteins in metastatic and non metastatic variants of the BSp73 tumor. Cancer Res 46: 785–790, 1986
Connell ND, Rheinwald JG: Regulation of cytoskeletal composition in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 34: 245–253, 1983
LaRocca PJ, Rheinwald JG: Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. Cancer Res 44: 2991–2999, 1984
Gunther A, Kinjo M, Winter H, Sonka J, Volm M: Differential expression of intermediate-filament proteins in murine sarcoma 180 ascites or solid tumor. Cancer Res 44: 2590–2594, 1984
Kinjo M, Winter H, Schweizer J: Differential expression of intermediate filament proteins in two rat ascites hepatoma lines of common origin. Carcinogenesis 5: 1249–1255, 1984
Ramaekers FCS, Haag D, Kant A, Moesker O, Jap PHK, Vooijs GP: Coexpression of keratin-and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci USA 80: 2618–2622, 1983
Virtanen I, Lehto V-P, Lehtonen E, Vartio T, Stenman S, Kurki P, Wagner O, Small JV, Dahl D, Bradley RA: Expression of intermediate filaments in cultured cells. J Cell Sci 50: 45–63, 1981
Lane EB, Hogan BLM, Kurkinen M, Garrels JI: Co-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryo. Nature (Lond) 303: 701–704, 1983
Summerhayes IC, Cheng Y-S, Sun T-T, Chen LB: Expression of keratin and vimentin intermediate filaments in rabbit bladder epithelial cells at different stages of benzo(a)pyrene-induced neoplastic progression. J Cell Biol 90: 63–69, 1981
Ben-Ze'ev A: Differential control of cytokeratins and vimentin synthesis by cell-cell contact and cell spreading in cultured epithelial cells. J Cell Biol 99: 1424–1433, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raz, A., Ben-Ze'ev, A. Cell-contact and-architecture of malignant cells and their relationship to metastasis. Cancer Metast Rev 6, 3–21 (1987). https://doi.org/10.1007/BF00047606
Issue Date:
DOI: https://doi.org/10.1007/BF00047606